Please wait...
Please let us know your thoughts on PATENTSCOPE or tell us what you feel is missing or how we could improve it.
The present invention provides a highly phosphorylated acid beta-glucocerebrosidase (GBA), which can be employed in an enzyme replacement therapy protocol to treat patients suffering from Gaucher's disease.